Leap Therapeutics Cash from Financing (TTM) Trends

Leap Therapeutics Inc (LPTX)

2.65 -0.09 (-3.28%) USD | NASDAQ | May 17, 16:00

2.65 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	0.028M
December 31, 2023	-0.03M
September 30, 2023	-0.03M
June 30, 2023	-0.029M
March 31, 2023	-0.029M
December 31, 2022	-0.21M
September 30, 2022	0.545M
June 30, 2022	97.81M
March 31, 2022	97.81M
December 31, 2021	98.04M
September 30, 2021	97.28M
June 30, 2021	-0.367M
March 31, 2021	48.41M
December 31, 2020	74.00M
September 30, 2020	73.98M
June 30, 2020	75.62M
March 31, 2020	28.10M
December 31, 2019	14.82M
September 30, 2019	14.80M
June 30, 2019	13.48M
March 31, 2019	13.22M

Date	Value
December 31, 2018	15.91M
September 30, 2018	33.84M
June 30, 2018	33.91M
March 31, 2018	32.92M
December 31, 2017	47.76M
September 30, 2017	36.59M
June 30, 2017	42.59M
March 31, 2017	48.57M
December 31, 2016	25.62M
September 30, 2016	27.15M
June 30, 2016	21.17M
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015	46.89M
December 31, 2014	46.89M
September 30, 2014	46.89M
June 30, 2014	13.31M
March 31, 2014	13.75M
December 31, 2013	13.75M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.367M

Minimum

Jun 2021

98.04M

Maximum

Dec 2021

36.70M

Average

14.81M

Median

Cash from Financing (TTM) Benchmarks